In July 2020, our Center, in collaboration with MAPS, trained the first cohort of MDMA psychotherapists to work on our approved research studies. Since then, the Center has run five additional MDMA- Assisted Therapy for PTSD educational retreats in collaboration with MAPS, and has trained approximately 250 therapists. These trainings provide education for investigators involved in approved research studies and raise awareness amongst clinicians about the participant-directed principle guided therapeutic approach to MDMA-AT. Our experience offering trainings and providing MDMA-AT in our clinical trials led us to develop Integrative MDMA-Assisted Therapy (IMAP) for PTSD. IMAP is a principle-guided, patient driven model that preserves the spirit of earlier models of psychedelic assisted therapy- with a focus on empathy, presence, and respect for self-directed healing- while integrating contemporary clinical models of PTSD and a comprehensive framework for attending to patient safety. In the future we will be exploring the use of AI in training and skills assessment. The Center is excited to offer this model to the field and future IMAP training opportunities will be posted on our webpage.